Electroporation (EP) combines short electric pulses to generate portions in the cell membranes. Combining Electroporation with Chemotherapy – administrated locally or intravenously – is called Electrochemotherapy. Electrochemotherapy makes it possible to deliver drugs through the membrane of cancer cells. The short, intense electric pulses make the cell membrane transiently permeable, allowing the chemotherapeutic substance to reach the cell DNA. The treatment can be used for cutaneous as well as subcutaneous tumours. Electrochemotherapy has been used to treat patients clinically with drugs such as bleomycin and cisplatin since the beginning of the 1990s. Electrochemotherapy is used in many countries around the world, and to date more than 4,000 patients have been treated using this method.

With its effective and flexible treatment capabilities, IQwave™ represents the next generation of electroporation devices. It has been developed to achieve positive clinical outcomes on a level not previously possible.

The IQwave™ offers unique advantages. The pre-programmed software optimises treatment for different types of tumours while the black panel mode allows for convenient use in operating rooms. The IQwave™ also offers an integrated tumour treatment database, making it easy for the physicians to monitor patient development. The foldable laptop design makes storage and transport very convenient. IQwave™ is equipped with a calibrating function which creates intelligent guidance for the use of different electrodes and applicators specially designed to make the treatment easier to perform and as effective as possible.

ChemoTechs IQwave™ Electroporation Device and it’s accessories are only available and marketed in Philippines and India.